KNUST GRANT: Call for PhD Position in Water Treatment Technologies

“Spiral wound ion-exchange membrane chemical-biological reactor for advanced treatment of water sources in Ghana contaminated with flouride and nitrate”


The occurrence of high fluoride concentration in groundwater causing fluorosis has become a health and geo-environmental issue in many countries of which Ghana is a part. Similarly, nitrate contamination in ground water is an emerging problem.

The research study aims to present an innovative technology, the spiral wound ion exchange membrane chemical-biological reactor (IEMR/IEMB) as a simple, efficient, easy-to-operate and cost-effective solution for the problem of fluoride and nitrate in Ghana.

This technology is based on a selective ion-exchange membrane via Donnan exchange mechanism.


The Regional Water and Environmental Sanitation Centre Kumasi (RWESCK) through the Department of Civil Engineering, KNUST and the Zukerberg Institute for Water Research (ZIWR) of the Ben Gurion University, Israel have jointly obtained a grant from the Mauerberger Foundation Fund to conduct a multi-country research in Israel and Ghana.

The joint research aims to use membrane technology, that is the IEMR/IEMB to develop a filter that can remove to substantial quantities, water contaminated with flouride and nitrate.


  • Students should be registered PhD students in KNUST
  • Should have academic background in one of the following fields: Civil Engineering, Chemical Engineering, Environmental Engineering, Water and Sanitation, Chemistry, Biochemistry or any relevant field of study
  • Should be available to commence the research by August 1, 2019.

Research Package

  • Research funds
  • Academic exchange at ZIWR laboratory, Israel for up to one (1) year
  • Travel grant and insurance
  • Monthly stipend

Application Requirements

Interested candidates should forward a letter of motivation, CV and list of publications to [email protected] by July 5, 2019. Shortlisted applicants will be contacted for an interview.

What's your take on this Latest Development?